How can the EU’s pharmaceutical legislation help tackle current challenges, including medicine shortages and antimicrobial resistance, across Europe? We put the question to Rainer Becker, Director for Medical Products and Innovation at DG SANTE.
Dr Takashi Nakamura from Hokkaido University challenges the potential of nano-tech based drug delivery system (Nano DDS) in the development of next-generation cancer immunotherapy.
The UK must address the increasing number of science skills shortages to maintain its world-leading position for medicines and vaccines research and development, says the Association of the British Pharmaceutical Industry (ABPI).
Research reveals that 70% of young men with anxiety report that their work performance and relationships are affected, yet well over half of them are still not seeking help.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group explains cutting-edge technology synergy in the personalised nanomedicine space, with a special focus on pharmaceutical nanomanufacturing
Open Access Government explores the exciting world of chemistry in the UK today, including heterocycles in pharmaceuticals and the importance of inspiring the next generation to work in the field
Marcin Rodzinka, Project Coordinator at Mental Health Europe explains how transparency between the pharma industry and health professionals can influence the quality of mental health care in Europe today
Prof Thomas Jaki from the Medical and Pharmaceutical Statistics Research Unit at Lancaster University provides an overview of the professional development courses offered at the unit
Life Sciences sector responds to the Business, Energy and Industrial Strategy (BEIS) Committee report on the impact of Brexit on the pharmaceutical sector
CEO of Medicines Discovery Catapult, Chris Molloy provides a compelling analysis of pharma R&D productivity and the discovery of new medicines and the role that the SME sector can play in this
The Association of the British Pharmaceutical Industry (ABPI) – representing global pharmaceutical businesses in the UK including GSK, AstraZeneca, Pfizer and Roche – has responded to Brexit speech by Prime Minister Theresa May
Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research gives an in-depth perspective on acute myeloid leukaemia (AML) and cytarabine pharmacogenomics
Acute myeloid...
As part of their partnership, Rhineland-Palatinate region of Germany and Rwanda foster the exchange of knowledge in hospital management, medical professions and psychiatric care...
Professor of Organic Chemistry at the University of York and Chairman of the Royal Society of Chemistry’s Heterocyclic and Synthesis Group, Peter O’Brien explores...
Prof Thomas Jaki from the Medical and Pharmaceutical Statistics Research Unit at Lancaster University explores a novel approach to Ph.D. training for those in the pharmaceutical industry
